ÂÜÀòÂÒÂ×

Travis has more than 25 years of experience in pharmaceutical and medical device manufacturing operations, including managing a commercial launch of numerous pharmaceutical and combination products. Travis came to Tarsus from Corcept Therapeutics, where he led manufacturing operations for late phase and commercial products, including Korlym®. Prior to this, he was the Vice President of Commercial Operations at CS Bio, leading commercial peptide production and supply chain operations. He joined CS Bio from Heron Therapeutics, where he built and led the manufacturing operations team, launching the company’s first commercial drug device combination product, Sustol®.

Travis started his pharmaceutical career at CV Therapeutics, where he launched Ranexa® and Lexiscan®, and continued with Gilead Sciences after it acquired CV Therapeutics, where he was responsible for, among other duties, the commercial API production of Viread®, Truvada®, and Atripla®. Travis holds a BS in chemical engineering from the University of California at Santa Barbara.